Medical university Graz
Graz, 8020, Austria
NCT Number: NCT01538485
In this pilot study the investigators aim to investigate the effects of vitamin D supplementation on regulatory FoxP3+ T cells in the gastrointestinal mucosa in healthy women and men.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 4
Graz, 8020, Austria
This is a monocentric, open pilot study, with the aim to evaluate the effect of vitamin d supplementation on regulatory FoxP3+ T cells in the gastrointestinal mucosa in healthy women and men.
The primary goal is to evaluate the influence of vitamin D supplementation on the regulatory FoxP3+ T cells in the gastrointestinal mucosa under controlled conditions within 2 months.
The secondary study goals are to evaluate the effect of vitamin D supplementation on peripheral induced tregs and on other important immune cells in the tissue (NK, NKT cells and LPCD) and in the blood (NK, NKT cells, Th17, Th1, Th2 cells) within 2 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
weekly dose (based on 70IU KG body weight/day)
Other names: Oleovit D3
Time frame: 2 months
the effects of vitamin D on regulatory FOXP3+ T cells will be measured at basal and after 2 months
Time frame: 2 months
Time frame: 2 months
Medical University of Graz
Other
Pilot Study to Assess the Effects of Vitamin D Supplementation on the Number of Regulatory FoxP3+ T Cells in the Gastrointestinal Mucosa in Healthy Women and Men: Step 3 in the Austrian Diabetes Prevention Programme
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05192720
Allergic Asthma, Allergic Rhinoconjunctivitis
Lørenskog, Akershus, Norway
View Trial DetailsNCT04525456
Immune Tolerance, Infections
Singapore
View Trial DetailsNCT03383211
Actinomycetales Infections, Bacterial Infections
Chisinau, Moldova
View Trial DetailsNCT02541916
Immune Tolerance, Immunosuppression
Toronto, Ontario, Canada
View Trial Details